JP2971291B2 - Production method of optically active 2-aminobutyric acid - Google Patents

Production method of optically active 2-aminobutyric acid

Info

Publication number
JP2971291B2
JP2971291B2 JP13176893A JP13176893A JP2971291B2 JP 2971291 B2 JP2971291 B2 JP 2971291B2 JP 13176893 A JP13176893 A JP 13176893A JP 13176893 A JP13176893 A JP 13176893A JP 2971291 B2 JP2971291 B2 JP 2971291B2
Authority
JP
Japan
Prior art keywords
aminobutyric acid
optically active
salt
acid
toluenesulfonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP13176893A
Other languages
Japanese (ja)
Other versions
JPH06340599A (en
Inventor
正 中谷
龍藏 吉岡
克司 森松
洋康 世古
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Priority to JP13176893A priority Critical patent/JP2971291B2/en
Publication of JPH06340599A publication Critical patent/JPH06340599A/en
Application granted granted Critical
Publication of JP2971291B2 publication Critical patent/JP2971291B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、各種医薬品または農薬
の原料として有用な光学活性2−アミノ酪酸の新規な製
法、さらに詳しくは、新規な2−アミノ酪酸・p−トル
エンスルホン酸塩を用い、優先晶析法を利用して高純度
の光学活性2−アミノ酪酸を工業的に製造する方法に関
する。
The present invention relates to a novel process for producing optically active 2-aminobutyric acid, which is useful as a raw material for various pharmaceuticals or agricultural chemicals, and more particularly, to a process using a novel 2-aminobutyric acid / p-toluenesulfonate. And a method for industrially producing high-purity optically active 2-aminobutyric acid using a preferential crystallization method.

【0002】[0002]

【従来の技術】光学活性2−アミノ酪酸はα−アミノ酸
の一種であり、近年キラルプール剤や不斉合成の触媒の
原料として重要度が一段と増しつつある。また、D−体
は抗生物質の修飾剤をはじめ各種医薬品の原料として注
目を集めている物質である。光学活性2−アミノ酪酸の
製造法としては、光学活性トランス−1,2−シクロヘ
キサンジカルボン酸無水物を光学分割剤に用いてラセミ
型2−アミノ酪酸をジアステレオマー光学分割する方法
が報告されている(日本化学会誌,(6)765(19
79))。しかし、この方法は光学分割剤が特殊な試薬
で市販されていないため調製が必要であること、またア
ミド化結合させて光学分割するため、分割後遊離の光学
活性2−アミノ酪酸を得るためには塩酸で加水分解しな
ければならず、面倒な上にラセミ化する危険性があり、
必ずしも有利な方法とはいえない。
2. Description of the Related Art Optically active 2-aminobutyric acid is a kind of α-amino acid, and its importance as a raw material for a chiral pool agent or a catalyst for asymmetric synthesis has been increasing in recent years. The D-form is a substance that has attracted attention as a raw material for various pharmaceuticals, including antibiotic modifiers. As a method for producing optically active 2-aminobutyric acid, a method for diastereomeric optical resolution of racemic 2-aminobutyric acid using optically active trans-1,2-cyclohexanedicarboxylic anhydride as an optical resolving agent has been reported. (Chemical Society of Japan, (6) 765 (19
79)). However, this method requires preparation since the optical resolving agent is not commercially available as a special reagent, and also requires an amidation bond to perform optical resolution, so that a free optically active 2-aminobutyric acid can be obtained after the resolution. Must be hydrolyzed with hydrochloric acid, and there is a risk of troublesome racemization,
This is not always an advantageous method.

【0003】また、ラセミ型N−アセチル−2−アミノ
酪酸のアンモニウム塩として優先晶析光学分割する方法
が報告されている(Bull.Chem.Soc.Jp
n.,60(3),947(1987))。しかし、こ
の方法は遊離の2−アミノ酪酸を一旦N−アセチル化し
た後、さらにアンモニウム塩に誘導しなければならず、
しかも分割後もこれらの除去が必要であり、さらに分割
効率もよくないので工業的に有利とはいえない。したが
って、工業的に有利に製造しうる光学活性2−アミノ酪
酸の新規な製造法が求められていた。
Further, a method has been reported for preferential crystallization optical resolution as an ammonium salt of racemic N-acetyl-2-aminobutyric acid (Bull. Chem. Soc. Jp.).
n. , 60 (3), 947 (1987)). However, in this method, once free 2-aminobutyric acid is once N-acetylated, it must be further derivatized to an ammonium salt.
Moreover, these must be removed after the division and the division efficiency is not good, so that it is not industrially advantageous. Therefore, a new method for producing optically active 2-aminobutyric acid which can be produced industrially advantageously has been demanded.

【0004】[0004]

【発明が解決しようとする課題】本発明者らは上述した
従来の欠点を克服すべく鋭意研究を進めた結果、経済的
でかつ工業的に平易な操作で光学活性な2−アミノ酪酸
を効率よく調製することができる優先晶析光学分割法を
見いだした。優先晶析法の原理はたとえばジェー ジェ
クエス、エー コレット、エス、エッチ ワイレン著
「エナンチオマーズ、ラセメート、アンド レゾリュウ
ション」ジェー ウイリー アンド サン、ニューヨー
ク(1981)に記載されているように周知であり、通
常ラセミ体の過飽和溶液に一方の光学活性体を接種し
て、接種したのと同じ光学活性体を分離取得する方法で
ある。この方法はジアステレオマー法のように特殊でか
つ高価な光学活性な分割剤を必要としないので工業的に
有利な分割方法といわれている。しかしこの方法が有利
に適用できるのは、一般に当該ラセミ体の結晶がラセミ
混合物を形成する場合に限られる。しかしいかなる化合
物が結晶化してラセミ混合物を形成するか、そして優先
晶析ができるかは不明であり、しかもその規則性もな
い。すなわち、この光学分割法を適用しうるラセミ混合
物を見いだすには一つ一つ2−アミノ酪酸の塩の結晶を
調製し同定することが必要である。通常ラセミ混合物を
形成する確率は極めて低く、形成するのはむしろ特殊な
場合と解釈できる。したがって、この様な条件を満足す
る化合物を見いだすには非常な努力を払わなければなら
ない。
SUMMARY OF THE INVENTION The present inventors have made intensive studies to overcome the above-mentioned drawbacks, and as a result, have been able to efficiently produce optically active 2-aminobutyric acid by a simple operation economically and industrially. A preferred crystallization optical resolution method that can be well prepared has been found. The principle of the preferential crystallization method is well known, for example, as described in J. Jesques, E. Colette, S., and Et Wylen, enantiomers, racemates, and resolution, J. Willie and Sun, New York (1981); Usually, one of the racemic supersaturated solutions is inoculated with one optically active substance, and the same optically active substance as inoculated is separated and obtained. This method is said to be industrially advantageous because it does not require a special and expensive optically active resolving agent unlike the diastereomer method. However, this method is advantageously applicable only generally when the racemic crystals form a racemic mixture. However, it is not known what compounds crystallize to form a racemic mixture and whether preferential crystallization can be achieved, and there is no regularity. That is, in order to find a racemic mixture to which this optical resolution method can be applied, it is necessary to prepare and identify crystals of a salt of 2-aminobutyric acid one by one. Usually, the probability of forming a racemic mixture is extremely low, and formation can be interpreted as a rather special case. Therefore, great effort must be made to find a compound that satisfies such conditions.

【0005】[0005]

【課題を解決するための手段】本発明者らは、2−アミ
ノ酪酸の効率のよい光学分割法について種々検討を重ね
た結果、2−アミノ酪酸を単にp−トルエンスルホン酸
との塩にするだけで、その塩がラセミ混合物を形成する
ことを見いだし、さらにラセミ体塩と光学活性体塩との
溶解度特性から効率よく光学活性体塩とラセミ体塩とに
分離できる優先晶析光学分割法を完成した。すなわち、
本発明は医薬、農薬の原料として有用な光学活性2−ア
ミノ酪酸を従来法に比べて安価に、且つ工業的に有利に
製造しうる新規製法、ならびにそれに用いる新規2−ア
ミノ酪酸・p−トルエンスルホン酸塩を提供するもので
ある。
The present inventors have conducted various studies on an efficient optical resolution method of 2-aminobutyric acid and found that 2-aminobutyric acid is simply converted into a salt with p-toluenesulfonic acid. Alone, and found that the salt forms a racemic mixture. Furthermore, a preferential crystallization optical resolution method capable of efficiently separating the optically active salt and the racemic salt from the solubility properties of the racemic salt and the optically active salt was found. completed. That is,
The present invention provides a novel method for producing optically active 2-aminobutyric acid, which is useful as a raw material for pharmaceuticals and agricultural chemicals, at a lower cost and in an industrially advantageous manner than the conventional method, and a novel 2-aminobutyric acid / p-toluene used therefor. It provides a sulfonate.

【0006】本発明によれば、光学分割すべき2−アミ
ノ酪酸をまず新規な2−アミノ酪酸・p−トルエンスル
ホン酸塩に導き、これを優先晶析法を利用して光学分割
した後、得られた光学活性2−アミノ酪酸・p−トルエ
ンスルホン酸塩を分解することにより、所望の光学活性
2−アミノ酪酸を高純度、高収率にて製造する。
According to the present invention, 2-aminobutyric acid to be optically resolved is first introduced into a novel 2-aminobutyric acid / p-toluenesulfonate, which is optically resolved using a preferential crystallization method. The desired optically active 2-aminobutyric acid is produced in high purity and high yield by decomposing the obtained optically active 2-aminobutyric acid / p-toluenesulfonic acid salt.

【0007】本発明に用いる2−アミノ酪酸・p−トル
エンスルホン酸塩は、水または水溶性有機溶媒中にp−
トルエンスルホン酸を溶解し、ここに2−アミノ酪酸を
徐々に加え、この溶液を適当な濃度に濃縮し、析出した
結晶を分離採取することにより容易に得ることができ
る。この際、p−トルエンスルホン酸をそのアルカリ金
属塩またはアルカリ土類金属塩として用いることもでき
るが、その場合は、溶液中に塩酸、硫酸等の鉱酸を存在
させて上記操作を行えばよい。該2−アミノ酪酸・p−
トルエンスルホン酸塩は、上記のように結晶として分離
採取されるが、工業的実施に際しては結晶として必ずし
も単離する必要はなく、2−アミノ酪酸・p−トルエン
スルホン酸塩の溶液をそのまま光学分割に使用すること
ができ、その場合、該塩の過飽和溶液として用いるのが
好ましい。なお、上記2−アミノ酪酸・p−トルエンス
ルホン酸塩としては、ラセミ型2−アミノ酪酸・p−ト
ルエンスルホン酸塩、または、いずれか一方の光学活性
2−アミノ酪酸がより過剰に含まれる光学活性2−アミ
ノ酪酸の混合物から得られる、いずれか一方の光学活性
体塩が過剰に存在する2−アミノ酪酸・p−トルエンス
ルホン酸塩をあげることができる。
The 2-aminobutyric acid / p-toluenesulfonate used in the present invention is p-toluene in water or a water-soluble organic solvent.
It can be easily obtained by dissolving toluenesulfonic acid, gradually adding 2-aminobutyric acid thereto, concentrating the solution to an appropriate concentration, and separating and collecting the precipitated crystals. At this time, p-toluenesulfonic acid can be used as its alkali metal salt or alkaline earth metal salt, in which case the above operation may be performed in the presence of a mineral acid such as hydrochloric acid or sulfuric acid in the solution. . The 2-aminobutyric acid / p-
Toluenesulfonic acid salt is separated and collected as crystals as described above, but it is not always necessary to isolate it as crystals in industrial practice, and a solution of 2-aminobutyric acid / p-toluenesulfonic acid salt is directly subjected to optical resolution. In such a case, it is preferable to use as a supersaturated solution of the salt. As the 2-aminobutyric acid / p-toluenesulfonate, racemic 2-aminobutyric acid / p-toluenesulfonate, or an optically active 2-aminobutyric acid in which either one is more excessively contained There can be mentioned 2-aminobutyric acid / p-toluenesulfonic acid salt obtained from a mixture of active 2-aminobutyric acids, in which either one of the optically active salts is present in excess.

【0008】本発明の光学分割を実施するためには、先
ずラセミ型2−アミノ酪酸・p−トルエンスルホン酸塩
の過飽和溶液またはいずれか一方の光学活性体塩が過剰
に存在する2−アミノ酪酸・p−トルエンスルホン酸塩
の過飽和溶液を調製する。通常、ラセミ型2−アミノ酪
酸・p−トルエンスルホン酸塩またはいずれか一方の光
学活性体塩を過剰に含有する塩の混合物を高温で飽和溶
液とした後、冷却あるいは濃縮すればよい。工業的には
高温で飽和したものを徐冷し、過飽和溶液とする方法が
よい。
In order to carry out the optical resolution of the present invention, first, a supersaturated solution of racemic 2-aminobutyric acid / p-toluenesulfonic acid salt or 2-aminobutyric acid in which one of the optically active salts is present in excess. Prepare a supersaturated solution of p-toluenesulfonic acid salt. Usually, a racemic 2-aminobutyric acid / p-toluenesulfonate salt or a mixture of salts containing one of the optically active salts in excess is converted into a saturated solution at a high temperature, and then cooled or concentrated. Industrially, it is preferable to gradually cool a material saturated at a high temperature to obtain a supersaturated solution.

【0009】使用する溶媒は水またはメタノール、エタ
ノール、プロパノール、イソプロパノール、ブタノー
ル、シクロヘキサノール等のアルコール類、アセトン、
メチルエチルケトン等のケトン類、酢酸、プロピオン
酸、ハロゲノ酢酸等の低級脂肪酸類、アセトニトリル、
ジメチルホルムアミド、ジメチルアセトアミド、ジメチ
ルスルホキシド、N,N’−ジメチルイミダゾリジノ
ン、N−メチルピロリドン等の非プロトン性極性溶媒、
ジオキサン等のエーテル類の水溶性有機溶媒と水との混
合溶媒が使用可能である。過飽和溶液中の2−アミノ酪
酸・p−トルエンスルホン酸塩の濃度は分割時の温度に
よっても異なるが、溶媒が水であるときは8〜15W/
V%程度で、混合溶媒を使用する場合は、15〜35W
/V%程度がよい。
The solvent used is water or alcohols such as methanol, ethanol, propanol, isopropanol, butanol, cyclohexanol, acetone,
Ketones such as methyl ethyl ketone, acetic acid, propionic acid, lower fatty acids such as halogenoacetic acid, acetonitrile,
Aprotic polar solvents such as dimethylformamide, dimethylacetamide, dimethylsulfoxide, N, N'-dimethylimidazolidinone, N-methylpyrrolidone,
A mixed solvent of water and a water-soluble organic solvent of ethers such as dioxane can be used. The concentration of 2-aminobutyric acid / p-toluenesulfonate in the supersaturated solution varies depending on the temperature at the time of division, but when the solvent is water, 8 to 15 W /
About V%, and when a mixed solvent is used, 15 to 35 W
/ V% is good.

【0010】光学活性の2−アミノ酪酸・p−トルエン
スルホン酸塩は通常上記のようにして調製したラセミ体
塩の過飽和溶液に種晶を接種することにより得られる。
この接種に使用する種晶は当然光学的に高純度のものが
好ましい。接種量は多いほど好ましいが、通常溶質量の
1〜5%で充分である。一方の光学活性体塩が過剰に存
在する過飽和溶液に同じ光学活性体塩を接種し、同種の
光学活性体塩を優先晶析させる場合、その溶液の旋光度
は光学活性体塩の優先晶析が進むにつれて次第に減少
し、いずれはその方向が逆転するので、通常晶析量は溶
存していた光学活性体塩の1.5〜2.5倍で打ち切る
のが好ましい。この場合の接種量は、溶質量の0.1%
以下でも充分である。析出晶を採取した残りの母液は、
ラセミ体塩を加えて過飽和溶液とし、母液中に過剰に存
在している光学活性体塩と同種の光学活性体塩を接種
し、優先晶析を上記と同様に行うことによって他方の光
学活性体塩を得ることができる。また、一般に知られて
いるように過飽和溶液状態を安定化するために適当な共
存塩、たとえば2−アミノ酪酸の鉱酸塩(塩酸塩、硫酸
塩など)、2−アミノ酪酸の有機酸塩(ベンゼンスルホ
ン酸塩、アルキルベンゼンスルホン酸塩、置換ベンゼン
スルホン酸塩など)を添加すると、より効率よく光学分
割ができる場合がある。上記の優先晶析は、バッチ式で
も連続式でも実施することができる。
The optically active 2-aminobutyric acid / p-toluenesulfonate is usually obtained by inoculating a supersaturated solution of the racemic salt prepared as described above with a seed crystal.
The seed crystal used for this inoculation is naturally preferably of optically high purity. The larger the inoculation amount, the better, but usually 1 to 5% of the dissolved mass is sufficient. When the same optically active salt is inoculated into a supersaturated solution in which one optically active salt is present in excess, and the same type of optically active salt is preferentially crystallized, the optical rotation of the solution is determined by the preferential crystallization of the optically active salt. Gradually decreases, and eventually the direction is reversed. Therefore, it is usually preferable that the amount of crystallization is usually cut off at 1.5 to 2.5 times the amount of the dissolved optically active salt. Inoculation amount in this case is 0.1% of dissolved mass
The following is sufficient. The remaining mother liquor from which the precipitated crystals were collected,
A racemic salt is added to make a supersaturated solution, and the same optically active salt as the optically active salt present in excess in the mother liquor is inoculated, and the preferential crystallization is performed in the same manner as described above to thereby obtain the other optically active salt. Salt can be obtained. In addition, as is generally known, coexisting salts suitable for stabilizing a supersaturated solution state, for example, mineral salts of 2-aminobutyric acid (hydrochloride, sulfate, etc.) and organic acid salts of 2-aminobutyric acid ( Addition of benzenesulfonate, alkylbenzenesulfonate, substituted benzenesulfonate, etc.) may allow more efficient optical resolution. The above-mentioned preferential crystallization can be carried out by a batch system or a continuous system.

【0011】この様にして得られた光学活性2−アミノ
酪酸・p−トルエンスルホン酸塩が、光学的に純粋でな
い場合は水または前記に示した水溶性有機溶媒と水との
混合溶媒から再結晶することによって、容易により高純
度の光学活性体塩とすることができる。この様にして得
られた光学活性2−アミノ酪酸・p−トルエンスルホン
酸塩は水または水溶性有機溶媒あるいはそれらの混合溶
媒に溶解、または分散せしめ、常法により、例えば、水
酸化ナトリウム、トリエチルアミンなどを加えて、中和
するかまたはイオン交換樹脂に通す方法によって塩を分
解すれば光学活性2−アミノ酪酸が容易に得られる。
When the optically active 2-aminobutyric acid / p-toluenesulfonate obtained in this way is not optically pure, it is re-used from water or the above-mentioned mixed solvent of water-soluble organic solvent and water. By crystallizing, an optically active salt with higher purity can be easily obtained. The optically active 2-aminobutyric acid / p-toluenesulfonate thus obtained is dissolved or dispersed in water or a water-soluble organic solvent or a mixed solvent thereof, and is dissolved in a conventional manner, for example, sodium hydroxide, triethylamine. If the salt is decomposed by a method such as neutralization or passage through an ion exchange resin, optically active 2-aminobutyric acid can be easily obtained.

【0012】[0012]

【実施例】以下に実施例によって本発明を詳細に説明す
る。 実施例1 p−トルエンスルホン酸・1水和物48.4gを水50
mlに溶解し、DL−2−アミノ酪酸25gを加え50
℃に加熱下完全に溶解した。この溶液を減圧濃縮して乾
固体とした後、アセトン150mlを加え、析出晶を濾
過してアセトンで洗浄後乾燥してDL−2−アミノ酪酸
・p−トルエンスルホン酸塩62.4gを得た。 収率 93.6% m.p.:153〜156℃ IR(KBr)cm−1:3420,2950,174
5,1600,1520,1170,1040,810 NMR(DMSO−d)δ:0.93(t,3H,J
=7.5),1.73−1.87(m,2H),2.2
9(s,3H),3.87(s,1H),7.12
(d,2H,J=8.2),7.49(d,2H,J=
8.0),8.20(s,3H) 元素分析(C1117NSとして): 計算値 C:47.99,H:6.22,N:5.09 測定値 C:48.03,H:6.20,N:5.11
The present invention will be described in detail with reference to the following examples. Example 1 48.4 g of p-toluenesulfonic acid monohydrate was added to 50 parts of water.
dissolved in 50 ml, and added with 25 g of DL-2-aminobutyric acid.
The solution was completely dissolved by heating to ° C. The solution was concentrated under reduced pressure to dry solid, 150 ml of acetone was added, the precipitated crystal was filtered, washed with acetone and dried to obtain 62.4 g of DL-2-aminobutyric acid / p-toluenesulfonic acid salt. . Yield 93.6% m. p. : 153 to 156 ° C IR (KBr) cm -1 : 3420, 2950, 174
5,1600,1520,1170,1040,810 NMR (DMSO-d 6) δ: 0.93 (t, 3H, J
= 7.5), 1.73-1.87 (m, 2H), 2.2
9 (s, 3H), 3.87 (s, 1H), 7.12
(D, 2H, J = 8.2), 7.49 (d, 2H, J =
8.0), 8.20 (s, 3H ) as elemental analysis (C 11 H 17 O 5 NS ): Calculated C: 47.99, H: 6.22, N: 5.09 measurements C: 48 .03, H: 6.20, N: 5.11

【0013】実施例2 p−トルエンスルホン酸・1水和物18.8gを水30
mlに溶解し、D−2−アミノ酪酸10gを加え50℃
に加熱下完全に溶解した。この溶液を以下実施例1と同
様に処理してD−2−アミノ酪酸・p−トルエンスルホ
ン酸塩26.1gを得た。 収率 99.3% m.p.:186〜188℃ [α] 25:−11.6°(c=1,メタノール) IR(KBr)cm−1:3420,2950,174
5,1600,1520,1170,1040,810 NMR(DMSO−d)δ:0.93(t,3H,J
=7.5),1.73−1.87(m,2H),2.2
9(s,3H),3.87(s,1H),7.12
(d,2H,J=8.2),7.49(d,2H,J=
8.0),8.20(s,3H) 元素分析(C1117NSとして): 計算値 C:47.99,H:6.22,N:5.09 測定値 C:48.11,H:6.19,N:5.09
Example 2 18.8 g of p-toluenesulfonic acid monohydrate was added to 30 parts of water.
dissolved in 50 ml, and added with 10 g of D-2-aminobutyric acid at 50 ° C.
Completely dissolved under heating. This solution was treated in the same manner as in Example 1 to obtain 26.1 g of D-2-aminobutyric acid / p-toluenesulfonic acid salt. Yield 99.3% m.p. p. : 186 to 188 ° C [α] D 25 : -11.6 ° (c = 1, methanol) IR (KBr) cm -1 : 3420, 2950, 174
5,1600,1520,1170,1040,810 NMR (DMSO-d 6) δ: 0.93 (t, 3H, J
= 7.5), 1.73-1.87 (m, 2H), 2.2
9 (s, 3H), 3.87 (s, 1H), 7.12
(D, 2H, J = 8.2), 7.49 (d, 2H, J =
8.0), 8.20 (s, 3H ) as elemental analysis (C 11 H 17 O 5 NS ): Calculated C: 47.99, H: 6.22, N: 5.09 measurements C: 48 .11, H: 6.19, N: 5.09

【0014】実施例3 p−トルエンスルホン酸・1水和物9.4gを水30m
lに溶解し、L−2−アミノ酪酸5gを加え50℃に加
熱下完全に溶解した。この溶液を以下実施例1と同様に
処理してL−2−アミノ酪酸・p−トルエンスルホン酸
塩12.4gを得た。 収率 94.3% m.p.:186〜188℃ [α] 25:+11.6°(c=1,メタノール) IR(KBr)cm−1:3420,2950,174
5,1600,1520,1170,1040,810 NMR(DMSO−d)δ:0.93(t,3H,J
=7.5),1.73−1.87(m,2H),2.2
9(s,3H),3.87(s,1H),7.12
(d,2H,J=8.2),7.49(d,2H,J=
8.0),8.20(s,3H) 元素分析(C1117NSとして): 計算値 C:47.99,H:6.22,N:5.09 測定値 C:48.01,H:6.20,N:5.07
Example 3 9.4 g of p-toluenesulfonic acid monohydrate was added to 30 m of water.
and heated to 50 ° C. and completely dissolved. This solution was treated in the same manner as in Example 1 to obtain 12.4 g of L-2-aminobutyric acid / p-toluenesulfonic acid salt. Yield 94.3% m.p. p. : 186 to 188 ° C [α] D 25 : + 11.6 ° (c = 1, methanol) IR (KBr) cm -1 : 3420, 2950, 174
5,1600,1520,1170,1040,810 NMR (DMSO-d 6) δ: 0.93 (t, 3H, J
= 7.5), 1.73-1.87 (m, 2H), 2.2
9 (s, 3H), 3.87 (s, 1H), 7.12
(D, 2H, J = 8.2), 7.49 (d, 2H, J =
8.0), 8.20 (s, 3H ) as elemental analysis (C 11 H 17 O 5 NS ): Calculated C: 47.99, H: 6.22, N: 5.09 measurements C: 48 .01, H: 6.20, N: 5.07

【0015】実施例4 DL−2−アミノ酪酸・p−トルエンスルホン酸塩1
5.84g、D−2−アミノ酪酸・p−トルエンスルホ
ン酸塩0.80g、水10mlを三角マイエルに仕込み
50℃で加熱溶解し、この溶液をゆっくりと撹拌し30
℃まで冷却した。そこにD−2−アミノ酪酸・p−トル
エンスルホン酸塩の種晶0.01gを添加し、25℃ま
で徐々に冷却した後析出した結晶を濾別し、アセトンで
洗浄後乾燥してD−2−アミノ酪酸・p−トルエンスル
ホン酸塩1.44g([α] 25:−8.9°(c=
1,メタノール)、光学純度:76.7%)を得た。さ
らに、この濾過母液にDL−2−アミノ酪酸・p−トル
エンスルホン酸塩1.44gを加え50℃で加熱溶解
し、この溶液をゆっくりと撹拌し30℃まで冷却した。
そこに同温度でL−2−アミノ酪酸・p−トルエンスル
ホン酸塩の種晶0.01gを添加し、25.5℃まで徐
々に冷却した後、析出した結晶を濾別し、アセトンで洗
浄後乾燥してL−2−アミノ酪酸・p−トルエンスルホ
ン酸塩0.67gを([α] 25:+9.3°(c=
1,メタノール)、光学純度:80.2%)を得た。以
下、上記と同様にこの分割母液に取得した光学活性体塩
に相当するDL−2−アミノ酪酸・p−トルエンスルホ
ン酸塩を加える方法で、D−体塩とL−体塩を交互に各
1回光学分割し、それぞれD−2−アミノ酪酸・p−ト
ルエンスルホン酸塩0.89g([α] 25:−8.
1°(c=1,メタノール)、光学純度:69.8%)
およびL−2−アミノ酪酸・p−トルエンスルホン酸塩
0.69g([α] 25:+9.0°(c=1,メタ
ノール)、光学純度:77.5%)を得た。
Example 4 DL-2-aminobutyric acid / p-toluenesulfonic acid salt 1
5.84 g, 0.80 g of D-2-aminobutyric acid / p-toluenesulfonate, and 10 ml of water were charged into a triangular Meyer and dissolved by heating at 50 ° C., and the solution was stirred slowly.
Cooled to ° C. Thereto was added 0.01 g of a seed crystal of D-2-aminobutyric acid / p-toluenesulfonate, and after cooling gradually to 25 ° C., the precipitated crystal was separated by filtration, washed with acetone, dried and dried. 1.44 g of 2-aminobutyric acid / p-toluenesulfonate ([α] D 25 : -8.9 ° (c =
1, methanol) and optical purity: 76.7%). Further, 1.44 g of DL-2-aminobutyric acid / p-toluenesulfonate was added to the filtered mother liquor and dissolved by heating at 50 ° C., and the solution was slowly stirred and cooled to 30 ° C.
At the same temperature, 0.01 g of a seed crystal of L-2-aminobutyric acid / p-toluenesulfonate was added, and the mixture was gradually cooled to 25.5 ° C., and the precipitated crystal was separated by filtration and washed with acetone. After drying, 0.67 g of L-2-aminobutyric acid / p-toluenesulfonic acid salt was obtained ([α] D 25 : + 9.3 ° (c =
1, methanol) and optical purity: 80.2%). Hereinafter, in the same manner as described above, the D-form salt and the L-form salt are alternately added by a method of adding DL-2-aminobutyric acid / p-toluenesulfonic acid salt corresponding to the obtained optically active form salt to the split mother liquor. The solution was optically resolved once, and 0.89 g of D-2-aminobutyric acid / p-toluenesulfonate ([α] D 25 : −8.
1 ° (c = 1, methanol), optical purity: 69.8%)
And 0.69 g of L-2-aminobutyric acid / p-toluenesulfonate ([α] D 25 : + 9.0 ° (c = 1, methanol), optical purity: 77.5%).

【0016】実施例5 D−2−アミノ酪酸・p−トルエンスルホン酸塩1.4
4g([α] 25:−8.9°(c=1,メタノー
ル)、光学純度:76.7%)を含水アセトンから再結
晶してD−2−アミノ酪酸・p−トルエンスルホン酸塩
1.01g([α] 25:−11.6°(c=1,メ
タノール))を得た。この塩の光学純度は100%であ
り、融点、IRおよびNMRも実施例2で得たD−体塩
の標準品と一致した。さらにこの塩0.9gをメタノー
ル3mlに加熱溶解し、50℃でトリエチルアミン0.
33gを添加した。次いで室温下で2時間撹拌後、析出
した結晶を濾取し、メタノールで洗浄後乾燥してD−2
−アミノ酪酸0.30gを得た。 収率 90.0% m.p.:302〜306℃ [α] 25:−7.9°(c=4,HO) IR(KBr)cm−1:3440,3070,160
0,1420,1310,810 NMR(DMSO−d+DO)δ:0.88(t,
3H,J=7.5),1.66−1.75(m,2
H),3.16(t,1H,J=5.5) 元素分析(CNとして): 計算値 C:46.59,H:8.80,N:13.5
8 測定値 C:46.50,H:8.75,N:13.6
Example 5 D-2-aminobutyric acid / p-toluenesulfonate 1.4
4 g ([α] D 25 : -8.9 ° (c = 1, methanol), optical purity: 76.7%) was recrystallized from aqueous acetone to give D-2-aminobutyric acid / p-toluenesulfonate. 1.01 g ([α] D 25 : −11.6 ° (c = 1, methanol)) was obtained. The optical purity of this salt was 100%, and the melting point, IR and NMR were identical to those of the standard D-form salt obtained in Example 2. Further, 0.9 g of this salt was dissolved by heating in 3 ml of methanol, and triethylamine was added at 50 ° C.
33 g were added. Then, after stirring at room temperature for 2 hours, the precipitated crystals were collected by filtration, washed with methanol, and dried to obtain D-2.
-0.30 g of aminobutyric acid was obtained. Yield 90.0% m. p. : 302 to 306 ° C [α] D 25 : -7.9 ° (c = 4, H 2 O) IR (KBr) cm -1 : 3440, 3070, 160
0,1420,1310,810 NMR (DMSO-d 6 + D 2 O) δ: 0.88 (t,
3H, J = 7.5), 1.66-1.75 (m, 2
H), 3.16 (t, 1H , as J = 5.5) Elementary analysis (C 4 H 9 O 2 N ): Calculated C: 46.59, H: 8.80, N: 13.5
8 measured values C: 46.50, H: 8.75, N: 13.6
1

【0017】[0017]

【発明の効果】本発明によれば、ラセミ型2−アミノ酪
酸から容易に製造されるラセミ型2−アミノ酪酸・p−
トルエンスルホン酸塩を原料として優先晶析光学分割す
ることにより従来法に比べて効率よく高純度の光学活性
2−アミノ酪酸・p−トルエンスルホン酸塩を得ること
ができる。しかも、分割された光学活性2−アミノ酪酸
・p−トルエンスルホン酸塩は単に脱塩するだけで容易
に光学活性2−アミノ酪酸に導くことができる。したが
って、本発明は、従来法に比べ、光学活性2−アミノ酪
酸を安価に且つ容易に製造しうるものであり、優れた工
業的製造法となりうるものである。
According to the present invention, racemic 2-aminobutyric acid / p- is easily produced from racemic 2-aminobutyric acid.
High-purity optically active 2-aminobutyric acid / p-toluenesulfonate can be efficiently obtained by performing preferential crystallization optical resolution using toluenesulfonate as a raw material, as compared with the conventional method. Moreover, the split optically active 2-aminobutyric acid / p-toluenesulfonic acid salt can be easily led to optically active 2-aminobutyric acid simply by desalting. Therefore, the present invention can produce optically active 2-aminobutyric acid cheaply and easily as compared with the conventional method, and can be an excellent industrial production method.

───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.6,DB名) C07C 227/34 C07B 57/00 365 C07C 229/06 CA(STN) REGISTRY(STN)──────────────────────────────────────────────────の Continued on the front page (58) Field surveyed (Int. Cl. 6 , DB name) C07C 227/34 C07B 57/00 365 C07C 229/06 CA (STN) REGISTRY (STN)

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 2−アミノ酪酸・p−トルエンスルホン
酸塩を優先晶析法により光学分割した後、該塩を分解す
ることを特徴とする光学活性2−アミノ酪酸の製法。
1. A process for producing optically active 2-aminobutyric acid, which comprises optically resolving 2-aminobutyric acid / p-toluenesulfonate by preferential crystallization and decomposing the salt.
【請求項2】 2−アミノ酪酸・p−トルエンスルホン
酸塩。
2. 2-aminobutyric acid / p-toluenesulfonic acid salt.
JP13176893A 1993-06-02 1993-06-02 Production method of optically active 2-aminobutyric acid Expired - Fee Related JP2971291B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13176893A JP2971291B2 (en) 1993-06-02 1993-06-02 Production method of optically active 2-aminobutyric acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13176893A JP2971291B2 (en) 1993-06-02 1993-06-02 Production method of optically active 2-aminobutyric acid

Publications (2)

Publication Number Publication Date
JPH06340599A JPH06340599A (en) 1994-12-13
JP2971291B2 true JP2971291B2 (en) 1999-11-02

Family

ID=15065715

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13176893A Expired - Fee Related JP2971291B2 (en) 1993-06-02 1993-06-02 Production method of optically active 2-aminobutyric acid

Country Status (1)

Country Link
JP (1) JP2971291B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4135373B2 (en) * 2002-02-15 2008-08-20 味の素株式会社 Method for producing optically active β-phenylalanine derivative
WO2003082815A1 (en) * 2002-03-29 2003-10-09 Kaneka Corporation Method of heightening optical purity of 1-benzyl-3-aminopyrrolidine and salt for use therein
BRPI0515944B1 (en) * 2004-09-29 2021-11-09 Bayer Healthcare Llc PROCESS FOR THE PREPARATION OF 4-{4-[({[4-CHLORINE-3-(TRIFLUOROMETHYL)PHEN]AMINO}CARBONYL) AMINO]PHENOXY}NMETHYLPYRIDINE-2-CARBOXAMIDE
EP2292306B1 (en) * 2009-09-02 2013-05-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for separation of racemic compound-forming chiral substances by a cyclic crystallization process and a crystallization device

Also Published As

Publication number Publication date
JPH06340599A (en) 1994-12-13

Similar Documents

Publication Publication Date Title
US4415504A (en) p-Hydroxyphenylglycine.α-phenylethanesulfonate, process for production thereof and utilization thereof in resolution of p-hydroxyphenylglycine
JP2971291B2 (en) Production method of optically active 2-aminobutyric acid
US4151198A (en) Resolution of N-acyl-DL (+)-phenylalanines
KR100495107B1 (en) Optical separation method of 3- (para-chlorophenyl) -glutaramide
JP2011098975A (en) Chiral pure n-(trans-4-isopropyl-cyclohexylcarbonyl)-d-phenylalanine and method for producing crystal structure transformation product thereof
JP2526811B2 (en) Phenethylamine derivative and method for producing the same
JPH08157437A (en) Production of d-amino acid-n-(s)-alpha-alkylbenzylamide
JP4728548B2 (en) Method for producing optically active amino alcohol
US4551548A (en) Process for the recovery of S-(carboxymethyl)-(R)-cysteine and S-(carboxymethyl)-(S)-cysteine
JPS6025959A (en) Optical resolution of amino acid complex and dl-amino acid
US2921959A (en) Process of resolving dl-serine
JP3316917B2 (en) New phenylalanine salt crystals and their production
US6008403A (en) Method for producing optically active amino acid of derivative thereof having high optical purity
JPS593476B2 (en) Optically active chlorpheniramine/acylphenylglycine salt and method for producing the same
US2463939A (en) Phenylacetyl amino acid esters
JPS6354700B2 (en)
JPH078853B2 (en) Method for producing dopamine derivative
JPH08119921A (en) Resolution of diastereomer of dl-alpha-amino acid-n-(s)-alpha-alkylbenzylamide
JPH09143138A (en) Production of (e)-2',4'-dichloroacetophenone oxime
JPH035382B2 (en)
JPS61501704A (en) Method for producing optically active phenylalanine and their N-acyl derivatives and novel diastereomeric salts of these compounds
JPH0259817B2 (en)
JPS61172846A (en) Method of optical resolution of (+-)-2-chloroprorionic acid
JPH023627A (en) Production of optically active 1-methyl-3-phenylpropylamine
JPH0472824B2 (en)

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080827

Year of fee payment: 9

LAPS Cancellation because of no payment of annual fees